Arkolith/Insider Trading/CLYM/Form 4

Kolchinsky Peter

Director, 10% OwnerClimb Bio, Inc. (CLYM) · full profile →Form 4 · filed Dec 15, 2025
Net Buying
Open-Market Buys
$755K
Open-Market Sells
$0
Net Open-Market Flow
$755K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Buy(P)101K$2.86$290K3.4M
Dec 11, 2025Buy(P)213K$2.18$465K3.3M
Dec 11, 2025Disposed to issuer(D)20.4M—$03.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2025Grant(A)20.4M——20.4M

Transaction Codes

P
Open-market purchase
D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000616) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Climb Bio, Inc.

Build

Ask your agent about CLYM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001231919-25-000616"
Ask your agent
Use Arkolith to summarize insider buying and selling at Climb Bio, Inc.
over the last 90 days and cite the filings.